{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:28:47Z","timestamp":1794979727268,"version":"4.9.1"},"reference-count":140,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ijpharm.2012.06.055","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T04:00:43Z","timestamp":1341547243000},"page":"167-180","source":"Crossref","is-referenced-by-count":836,"title":["Cyclodextrins"],"prefix":"10.1016","volume":"453","author":[{"given":"Sergey V.","family":"Kurkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsteinn","family":"Loftsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.06.055_bib0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00044011-200828070-00002","article-title":"Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects. Two prospective, multicentre, open-label, parallel-group volunteer studies","volume":"27","author":"Abel","year":"2008","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0010","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1021\/jm011107f","article-title":"Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure\u2013activity relationships","volume":"45","author":"Adam","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0015","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1211\/jpp.60.11.0003","article-title":"Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of \u03b2-derivatives","volume":"60","author":"Alexanian","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0025","series-title":"Minutes of the Sixth International Symposium on Cyclodextrins","article-title":"New aspects in cyclodextrin toxicology","author":"Antlsperger","year":"1992"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0030","series-title":"Proceedings of the Eighth International Symposium on Cyclodextrins","article-title":"Toxicological comparison of cyclodextrins","author":"Antlsperger","year":"1996"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0035","series-title":"Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications","article-title":"Recent findings on safety profiles of cyclodextrins, cyclodextrin conjugates, and polypseudorotaxanes","author":"Arima","year":"2011"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1042\/cs0400137","article-title":"Human glomerular membrane porosity and filtration pressure: dextran clearance data analysed by theoretical models","volume":"40","author":"Arturson","year":"1971","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/00365516409060485","article-title":"The intravascular persistence of dextran of different molecular sizes in normal humans","volume":"1","author":"Arturson","year":"1964","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0050","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.bmc.2009.02.044","article-title":"Binary and ternary inclusion complexes of finasteride in HP beta CD and polymers: preparation and characterization","volume":"17","author":"Asbahr","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2007.02.034","article-title":"Alpha-cyclodextrin\/oil beads: an innovative self-assembling system","volume":"339","author":"Bochot","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0060","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/la052878f","article-title":"Self-assembly of b-cyclodextrin in water. Part 1: Cryo-TEM and dynamic and static light scattering","volume":"22","author":"Bonini","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0065","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0070","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jmb.2008.10.085","article-title":"Structural base for enzymatic cyclodextrin hydrolysis","volume":"385","author":"Buedenbender","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0075","first-page":"185","article-title":"Applications of cyclodextrins in cosmetic products: a review","volume":"53","author":"Buschmann","year":"2002","journal-title":"J. Cosmet. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mrc.2740","article-title":"Prilocaine\u2013cyclodextrin\u2013liposome: effect of pH variations on the encapsulation and topology of a ternary complex using 1H NMR","volume":"49","author":"Cabeca","year":"2011","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0085","doi-asserted-by":"crossref","DOI":"10.1208\/pt070379","article-title":"Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl \u03b2-cyclodextrin","volume":"7","author":"Chowdary","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0090","doi-asserted-by":"crossref","first-page":"12366","DOI":"10.1021\/la702052h","article-title":"Guest-free self-assembly of \u03b1-cyclodextrins leading to channel-type nano-fibrils as mesoporous framework","volume":"23","author":"Chung","year":"2007","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0095","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jpba.2008.11.003","article-title":"Physical\u2013chemical characterization of binary and ternary systems of ketoprofen with cyclodextrins and phospholipids","volume":"50","author":"Cirri","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01053637","article-title":"Aggregation of cyclodextrins: an explanation of the abnormal solubility of b-cyclodextrin","volume":"13","author":"Coleman","year":"1992","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2008.09.006","article-title":"Mathematical modeling of molecular diffusion through mucus","volume":"61","author":"Cu","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0110","doi-asserted-by":"crossref","first-page":"9600","DOI":"10.1021\/jp801951j","article-title":"Probe-induced self-aggregation of \u03b3-cyclodextrin: formation of extended nanotubular suprastructure","volume":"112","author":"Das","year":"2008","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/rtph.1998.1219","article-title":"Disposition of 14C-\u03b3-cyclodextrin in germfree and conventional rats","volume":"27","author":"De Bie","year":"1998","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0120","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/rtph.1998.1219","article-title":"Disposition of [14C]g-cyclodextrin in germ-free and conventional rats","volume":"27","author":"De Bie","year":"1998","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0125","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1128\/AAC.42.2.404","article-title":"Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children","volume":"42","author":"De Repentigny","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0130","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jchromb.2011.03.050","article-title":"Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography\/tandem mass spectrometry assay","volume":"879","author":"De Zwart","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0135","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0032-9592(03)00258-9","article-title":"Cyclodextrins and their uses: a review","volume":"39","author":"Del Valle","year":"2004","journal-title":"Process Biochem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0140","first-page":"72","article-title":"Regulatory update: the IPEC novel excipient safety evaluation procedure","volume":"33","author":"Demerlis","year":"2009","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0145","first-page":"111","article-title":"Pharmacokinetics of dextrans","volume":"6","author":"Deux","year":"2001","journal-title":"Curr. Trends Polym. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0150","series-title":"Cyclodextrins and Their Complexes","year":"2006"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0155","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.carbpol.2010.01.002","article-title":"Digestion of starch: in vivo and in vitro kinetic models used to characterise oligosaccharide or glucose release","volume":"80","author":"Dona","year":"2010","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0160","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1008094702632","article-title":"Interaction of hydroxy acids with b-cyclodextrin","volume":"33","author":"Fenyvesi","year":"1999","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0165","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1021\/ja01167a084","article-title":"Studies of the Schardinger dextrins. VI. The molecular size and structure of \u03b3-dextrin","volume":"72","author":"French","year":"1950","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0170","series-title":"Cyclodextrins in Pharmacy","author":"Fr\u00f6mming","year":"1994"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0175","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/pol.1975.130130608","article-title":"Preparation of cyclodextrin-containing polymers and their catalysis in ester-hydrolysis","volume":"13","author":"Furue","year":"1975","journal-title":"J. Polym. Sci., Polym. Lett. Ed."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1023065823358","article-title":"The aggregation of cyclodextrins as studied by photon correlation spectroscopy","volume":"44","author":"Gonz\u00e1lez-Gaitano","year":"2002","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0185","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fct.2005.03.007","article-title":"2-Hydroxypropyl-b-cyclodextrin (HP-b-CD): a toxicology review","volume":"43","author":"Gould","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0190","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejmech.2007.03.037","article-title":"Synthesis, characterization and in vitro release studies of a new acetazolamide\u2013HP-\u03b2-CD\u2013TEA inclusion complex","volume":"43","author":"Granero","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0195","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1128\/AAC.01540-09","article-title":"Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration","volume":"54","author":"Hafner","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10847-008-9491-8","article-title":"Ternary inclusion complexes of \u03b3-cyclodextrin with sodium 1-pyrenesulfonate and cationic and anionic organic compounds having an alkyl chain in aqueous solution","volume":"63","author":"Hamai","year":"2009","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0205","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.micron.2007.06.017","article-title":"Cyclodextrin-based aggregates and characterization by microscopy","volume":"39","author":"He","year":"2008","journal-title":"Micron"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(03)00389-2","article-title":"Solubilization of fluasterone in cosolvent\/cyclodextrin combinations","volume":"264","author":"He","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0215","first-page":"1","article-title":"Doxycycline and hydroxypropyl-\u03b2-cyclodextrin complex in poloxamer thermal sensitive hydrogel for ophthalmic delivery","author":"He","year":"2011","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0220","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1248\/cpb.58.769","article-title":"Simultaneous dissolution of naproxen and flurbiprofen from a novel ternary \u03b3-cyclodextrin complex","volume":"58","author":"Higashi","year":"2010","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0225","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1021\/cg900573w","article-title":"Incorporation of salicylic acid molecules into the intermolecular spaces of \u03b3-cyclodextrin\u2013polypseudorotaxane","volume":"9","author":"Higashi","year":"2009","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0230","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jps.22273","article-title":"Structural evaluation of crystalline ternary \u03b3-cyclodextrin complex","volume":"100","author":"Higashi","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0235","first-page":"117","article-title":"Phase-solubility techniques","volume":"4","author":"Higuchi","year":"1965","journal-title":"Adv. Anal. Chem. Instrum."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0240","series-title":"Cyclodextrins in Pharmaceutics, Cosmetic, and Biomedicine: Current and Future Industrial Applications","article-title":"Regulatory status of cyclodextrins in pharmaceutical products","author":"Hincal","year":"2011"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0245","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jps.2600810915","article-title":"Acid-catalyzed hydrolysis of maltosyl-b-cyclodextrin","volume":"81","author":"Hirayama","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1021\/js960213f","article-title":"Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation","volume":"86","author":"Irie","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijpharm.2008.07.011","article-title":"gCD\/HPgCD: synergistic solubilization","volume":"363","author":"Jansook","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0260","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2009.06.005","article-title":"Cyclodextrins as solubilizers: effects of excipients and competing drugs","volume":"379","author":"Jansook","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0265","doi-asserted-by":"crossref","first-page":"336","DOI":"10.18433\/J3M88B","article-title":"\u03b3CD\/HP\u03b3CD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension","volume":"13","author":"Jansook","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0270","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1248\/bpb.20.181","article-title":"Polysaccharides as drug carriers: biodisposition of fluorescein-labeled dextrins in mice","volume":"20","author":"Kaneo","year":"1997","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0275","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1021\/js980109t","article-title":"Inclusion of ziprasidone mesylate with b-cyclodextrin sulfobutyl ether","volume":"87","author":"Kim","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0280","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2125.2011.04000.x","article-title":"Population pharmacokinetic\u2013pharmacodynamic analysis for sugammadex-mediated reversal of rocuronium-induced neuromuscular blockade","volume":"72","author":"Kleijn","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0285","first-page":"60","article-title":"Application challenges and examples of new excipients in advanced drug delivery systems","volume":"14","author":"Koo","year":"2011","journal-title":"Am. Pharm. Rev."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0290","first-page":"330","article-title":"Complexation of weak acids and basis with cyclodextrins: effects of substrate ionization on the estimation and interpretation of association constants","volume":"1","author":"Krishnamoorthy","year":"1996","journal-title":"Int. J. Pharm. Adv."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0295","first-page":"144","article-title":"Preparation and evaluation of binary and ternary inclusion complex of itraconazole","volume":"2","author":"Kumari","year":"2010","journal-title":"Pharm. Lett."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0300","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1208\/s12249-010-9482-0","article-title":"Parenteral delivery of HP\u03b2CD: effects on drug\u2013HSA binding","volume":"11","author":"Kurkov","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0305","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(98)00147-1","article-title":"Preparation of amphiphilic cyclodextrin nanospheres using the emulsification solvent evaporation method. Influence of the surfactant on the preparation and hydrophobic drug loading","volume":"170","author":"Lemos-Senna","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0310","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1021\/js9801889","article-title":"Combined effect of complexation and pH on solubilization","volume":"87","author":"Li","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0315","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/js990159d","article-title":"Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs","volume":"88","author":"Li","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0320","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the cause of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0325","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today: Technol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1014520830813","article-title":"The driving forces in the inclusion complexation of cyclodextrins","volume":"42","author":"Liu","year":"2002","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0340","first-page":"733","article-title":"Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers","volume":"53","author":"Loftsson","year":"1998","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0345","first-page":"185","article-title":"Effects of 2-hydroxypropyl-b-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17b-estradiol","volume":"1","author":"Loftsson","year":"1989","journal-title":"Acta Pharm. Nord."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0350","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.2042-7158.2010.01030.x","article-title":"Pharmaceutical applications of cyclodextrins: basic science and product development","volume":"62","author":"Loftsson","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0355","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.2042-7158.2011.01279.x","article-title":"Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes","volume":"63","author":"Loftsson","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0360","doi-asserted-by":"crossref","unstructured":"Loftsson, T., Brewster, M.E., 2012. Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J. Pharm. Sci. 101, in press.","DOI":"10.1002\/jps.23077"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.044","article-title":"Cyclodextrins and their pharmaceutical applications","volume":"329","author":"Loftsson","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0370","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-5173(94)90155-4","article-title":"The effect of water-soluble polymers on drug\u2013cyclodextrin complexation","volume":"110","author":"Loftsson","year":"1994","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0375","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2005.05.042","article-title":"Evaluation of cyclodextrin solubilization of drugs","volume":"302","author":"Loftsson","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0380","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1517\/17425247.2.1.335","article-title":"Cyclodextrins in drug delivery","volume":"2","author":"Loftsson","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0385","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-5173(03)00334-X","article-title":"The effects of organic salts on the cyclodextrin solubilization of drugs","volume":"262","author":"Loftsson","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0390","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1773-2247(04)50003-5","article-title":"The effects of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs","volume":"14","author":"Loftsson","year":"2004","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0395","first-page":"25","article-title":"Preparation of solid drug\/cyclodextrin complexes of acidic and basic drugs","volume":"59","author":"Loftsson","year":"2004","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0400","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/jps.20992","article-title":"Effects of cyclodextrins on drug delivery through biological membranes","volume":"96","author":"Loftsson","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0405","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1208\/s12249-008-9055-7","article-title":"Carvedilol: solubilization and cyclodextrin complexation. A technical note","volume":"9","author":"Loftsson","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0410","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1002\/jps.22109","article-title":"Review of the basic and clinical pharmacology of sulfobutylether-b-cyclodextrin (SBECD)","volume":"99","author":"Luke","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0415","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1021\/ja972810p","article-title":"Studies of naphthyl-substituted \u03b2-cyclodextrins. Self-aggregation and inclusion of external guests","volume":"120","author":"Mcalpine","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0420","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/ALN.0b013e3182065c36","article-title":"Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients","volume":"114","author":"Mcdonagh","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0425","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/jps.2600840706","article-title":"Dose dependency of the kinetics of dextrans in rats: effects of molecular weight","volume":"84","author":"Mehvar","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0430","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/jps.2600810914","article-title":"Molecular-weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats","volume":"81","author":"Mehvar","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0435","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0008-6215(98)00193-1","article-title":"Non-covalent associations of cyclomaltooligosaccharides (cyclodextrins) with trans-b-carotene in water: evidence for the formation of large aggregates by light scattering and NMR spectroscopy","volume":"310","author":"Mele","year":"1998","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0440","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/02652040500286227","article-title":"Effect of drug physicochemical properties on in vitro characteristics of amphiphilic cyclodextrin nanospheres and nanocapsules","volume":"23","author":"Memi\u015fo\u011flu-Bilensoy","year":"2006","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0445","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijpharm.2009.11.035","article-title":"Self-assembled cyclodextrin aggregates and nanoparticles","volume":"387","author":"Messner","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0450","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1246\/bcsj.59.643","article-title":"Activity coefficients of dimethyl-\u03b2-cyclodextrin in aqueous solutions","volume":"59","author":"Miyajima","year":"1986","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0455","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1246\/bcsj.56.3556","article-title":"Viscosity B-coefficients, apparent molar volumes, and activity coefficients for \u03b1- and \u03b3-cyclodextrins in aqueous solutions","volume":"56","author":"Miyajima","year":"1983","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0460","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1128\/AAC.48.8.3151-3153.2004","article-title":"Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients","volume":"48","author":"Mohr","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 1","key":"10.1016\/j.ijpharm.2012.06.055_bib0465","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.yrtph.2004.05.008","article-title":"Safety assessment of \u03b3-cyclodextrin","volume":"39","author":"Munro","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0470","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0378-5173(03)00265-5","article-title":"Ternary systems of naproxen with hydroxypropyl-b-cyclodextrin and aminoacids","volume":"260","author":"Mura","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0475","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(96)00403-6","article-title":"Pharmacokinetic evaluation of polymeric carriers","volume":"21","author":"Nishikawa","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0480","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10847-009-9586-x","article-title":"Metal ion complexes with native cyclodextrins. An overview","volume":"65","author":"Norkus","year":"2009","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0485","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1023\/A:1016047215907","article-title":"The interaction of charged and uncharged drugs with neutral (HP-\u03b2-CD) and anionically charged (SBE7-\u03b2-CD) \u03b2-cyclodextrins","volume":"13","author":"Okimoto","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0490","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/1091581811423582","article-title":"Trends in excipient safety evaluation","volume":"30","author":"Osterberg","year":"2011","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0495","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bdd.747","article-title":"Sugammadex is cleared rapidly and primarily unchanged via renal excretion","volume":"32","author":"Peeters","year":"2011","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0500","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jps.20525","article-title":"The binding interaction of synthetic ozonide antimalarials with natural and modified b-cyclodextrins","volume":"95","author":"Perry","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0505","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2478\/v10007-009-0001-3","article-title":"Ternary complexation of carvedilol, \u03b2-cyclodextrin and citric acid for mouth-dissolving tablet formulation","volume":"59","author":"Pokharkar","year":"2009","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0510","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1002\/1521-3773(20011203)40:23<4417::AID-ANIE4417>3.0.CO;2-P","article-title":"From cyclodextrin assemblies to porous materials by silica templating","volume":"40","author":"Polarz","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0515","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0378-5173(95)04357-8","article-title":"A study on the differentiation between amorphous piroxicam:b-cyclodextrin complex and a mixture of the two amorphous components","volume":"129","author":"Redenti","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1520-6017(200001)89:1<1::AID-JPS1>3.0.CO;2-W","article-title":"Drug\/cyclodextrin\/hydroxy acid multicomponent systems. Properties and pharmaceutical applications","volume":"89","author":"Redenti","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0525","series-title":"Techniques of Solubilization of Drugs","article-title":"Alteration of apparent solubility through complexation","author":"Repta","year":"1985"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0530","doi-asserted-by":"crossref","first-page":"10959","DOI":"10.1021\/la7011638","article-title":"Self-assembly of \u03b2-cyclodextrin in water. 2. Electron spin resonance","volume":"23","author":"Rossi","year":"2007","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0535","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/anie.198003441","article-title":"Cyclodextrin inclusion compounds in research and industry","volume":"19","author":"Saenger","year":"1980","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0540","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1208\/s12249-009-9350-y","article-title":"Effect of auxiliary substances on complexation efficiency and intrinsic dissolution rate of gemfibrozil\u2013\u03b2-CD complexes","volume":"11","author":"Sami","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0545","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2009.04.035","article-title":"An efficient ternary complex of acetazolamide with HP-\u03b2-CD and TEA for topical ocular administration","volume":"138","author":"Santiago","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0550","first-page":"468","article-title":"Uber die Zul\u00e4ssigkeit des Warmhaltens von zum Gebu\u00df bestimmten Nahrungsmittel mittelst W\u00e4rme speichernder Apparate, sog. Thermophore","author":"Schardinger","year":"1903","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0555","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/BF02067497","article-title":"\u00dcber Thermophile Bakterien aus verschiedenen Speisen und Milch, sowie \u00fcber einige Umsetzungsprodukte derselben in kohlenhydrathaltigen N\u00e4hrl\u00f6sungen, darunter krystallisierte Polysaccharide (Dextrine) aus St\u00e4rke","volume":"6","author":"Schardinger","year":"1903","journal-title":"Z. Untersuch. Nahr. Genussm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0560","first-page":"188","article-title":"Bildung kristallisierter Polysaccharide (Dextrine) aus St\u00e4rkekleister durch Microben","volume":"29","author":"Schardinger","year":"1911","journal-title":"Zentralbl. Bakteriol. Parasitenk. Abt. II"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0565","first-page":"358","article-title":"Pharmacokinetics of low molecular (monovalent) dextran (Dx 1) in volunteers","volume":"19","author":"Schwarz","year":"1981","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0570","series-title":"4th Int. Symp. on Cyclodextrins","article-title":"The acid hydrolysis of cyclodextrins and linear olicgsaccharides, a comparative study","author":"Sch\u00f6nberger","year":"1988"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0575","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/(SICI)1096-9888(199808)33:8<729::AID-JMS687>3.0.CO;2-U","article-title":"Study of b-cyclodextrin\u2013ketakonazole\u2013tartaric acid multicomponent non-covalent association by positive and negative ion spray mass spectrometry","volume":"33","author":"Selva","year":"1998","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0580","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.tifs.2009.12.001","article-title":"Starch digestibility in food matrix: a review","volume":"21","author":"Singh","year":"2010","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0585","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.addr.2005.07.001","article-title":"The basics and underlying mechanisms of mucoadhesion","volume":"57","author":"Smart","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0590","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0192623307310945","article-title":"Cyclodextrins","volume":"36","author":"Stella","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0595","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1023\/A:1012136608249","article-title":"Cyclodextrins: their future in drug formulation and delivery","volume":"14","author":"Stella","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0600","series-title":"Mins. 5th International Symposium on Cyclodextrins","article-title":"Pharmacokinetic behavior and absolute bioavailability of hydroxypropyl-\u03b2-cyclodextrin after increasing doses in volunteers","author":"Szathmary","year":"1990"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0605","series-title":"Cyclodextrins and Their Uses","article-title":"The metabolism, toxicity and biological effects of cyclodextrins","author":"Szejtli","year":"1987"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0610","series-title":"Cyclodextrin Technology","author":"Szejtli","year":"1988"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0615","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/cr970022c","article-title":"Introduction and general overview of cyclodextrin chemistry","volume":"98","author":"Szejtli","year":"1998","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0620","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1351\/pac200476101825","article-title":"Past, present, and future of cyclodextrin research","volume":"76","author":"Szejtli","year":"2004","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0625","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1021\/js9704341","article-title":"Spontaneous opalescence of aqueous g-cyclodextrin solutions: complex formation or self-aggregation","volume":"87","author":"Szente","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0630","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0168-8278(96)80119-X","article-title":"Pharmacokinetics of dextran-70 in patients with cirrhosis and ascites undergoing therapeutic paracentesis","volume":"25","author":"Terg","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0635","series-title":"Cyclodextrins and Their Complexes: Chemistry, Analytical Methods, Applications","article-title":"Cyclodextrins in dispersed systems","author":"Trichard","year":"2006"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0640","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1248\/cpb.52.900","article-title":"Design and evaluation of cyclodextrin-based drug formulation","volume":"52","author":"Uekama","year":"2004","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0645","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10847-010-9746-z","article-title":"Inhibition of cyclodextrin acid hydrolysis by some inclusion complexes","volume":"69","author":"Vaitkus","year":"2011","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0650","first-page":"48","article-title":"Peculiarities of \u03b2-cyclodextrin acid hydrolysis","volume":"19","author":"Vaitkus","year":"2008","journal-title":"Chemija"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0655","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.yrtph.2004.05.011","article-title":"Disposition of 14C-\u03b1-cyclodextrin in germ-free and conventional rats","volume":"39","author":"Van Ommen","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0660","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5173(03)00065-6","article-title":"Solubility enhancement of low soluble biologically active compounds \u2013 temperature and cosolvent dependent inclusion complexation","volume":"256","author":"Viernstein","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0665","first-page":"536","article-title":"Sur la fermentation de la f\u00e9cule par l\u2019action du ferment butyrique","volume":"112","author":"Villiers","year":"1891","journal-title":"C. R. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0670","first-page":"357","article-title":"New drug sugammadex: a selective relaxant binding agent","volume":"74","author":"Welliver","year":"2006","journal-title":"AANA J."},{"issue":"Suppl. 2","key":"10.1016\/j.ijpharm.2012.06.055_bib0675","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00044011-200019002-00003","article-title":"An overview of host\u2013guest chemistry and its application to nonsteroidal anti-inflammatory drugs","volume":"19","author":"Wenz","year":"2000","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0680","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01041529","article-title":"Aggregation behavior of hydrophobically modified \u03b2-cyclodextrins in aqueous solution","volume":"25","author":"Witte","year":"1996","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0685","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcis.2005.11.014","article-title":"Investigation of g-cyclodextrin nanotube induced by N,N\u2032-diphenylbenzidine molecule","volume":"297","author":"Wu","year":"2006","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0690","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-3659(02)00367-X","article-title":"Liquid formulation of a novel non-fluorinated topical quinolone, T-3912, utilizing the synergic solubilizing effect of the combined use of magnesium ions and hydroxypropyl-b-cyclodextrin","volume":"86","author":"Yamakawa","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0695","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/j.1552-4604.1998.tb04465.x","article-title":"A pharmacokinetic study of intravenous intraconazole followed by oral administration of intraconazole capsules in patients with advanced human immunodeficiency virus infection","volume":"38","author":"Zhou","year":"1998","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.06.055_bib0700","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/A:1011041628797","article-title":"Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-b-CD to HP-b-CD","volume":"18","author":"Zia","year":"2001","journal-title":"Pharm. Res."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312006540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312006540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T05:39:28Z","timestamp":1594359568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312006540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0378517312006540"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.06.055","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}